IRCT20230603058376N1RecruitingPhase 1
Evaluation of the effect of arginine administration on height growth of Children in lower limit range
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Enrollment
- 76
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 5 years to 15 years (—)
- Sex
- All
Inclusion Criteria
- •Children in pre-pubertal ages
- •Absence of any underlying diseases
- •Not below the lower normal height limit
- •No indications for growth hormone prescription
Exclusion Criteria
- •Having reached sexual maturity
- •Presence of underlying diseases such as diabetes, hypothyroidism, or kidney diseases
- •Height below the lower normal limit
- •Past or current use of growth hormone
- •Sensitivity or adverse reactions to Vitamin D or Arginine
Investigators
Similar Trials
Not yet recruiting
Not Applicable
Effects of Arginine Supplementation associated with an Exercise Training Program in Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease, Unspecified / Chronic Obstructive Pulmonary DiseaseRBR-8rkwnwniversidade Federal de Ciências da Saúde de Porto Alegre - UFCSPA
Completed
Phase 3
Investigation of the effect of oral L-arginine on pulmonary hypertension in patients with thalassemia majorIRCT20191218045785N1Shahre-kord University of Medical Sciences50
Completed
Not Applicable
The effect of L- arginine supplementation on metabolic syndrome.Metabolic Syndrome.-IRCT2015120425245N2for research of Yazd Shahid Sadoughi University of Medical Sciences60
Recruiting
Phase 3
Effect of arginine on chronic anal fissureIRCT20190712044182N1Iran University of Medical Sciences76
Completed
Not Applicable
Assessment the effect of the amino acid L-arginine / calcium carbonate based bleaching and in-office tooth sensitivity in teeth whitening methodsIRCT2017011832043N1Mashhad University of Medical Sciences,Vice President of Research30